- Exchange: NASDAQ CM
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Biotech
Idera Pharmaceuticals Inc+ Add to Watchlist
IDRA:US3.1300 USD 0.0900 2.96%
As of 20:10:00 ET on 05/22/2015.
Company Profile for Idera Pharmaceuticals Inc (IDRA)
Idera Pharmaceuticals, Inc. is a biotechnology company. The Company develops therapeutics that modulate the immune response through Toll-like receptors. Idera is working on therapeutics for oncology, asthma/allergy, and infectious diseases.
Idera Pharmaceuticals Inc
Key Executives for Idera Pharmaceuticals Inc (IDRA)
|Vincent J Milano "Vin"President/CEO||Sudhir D Agrawal "Phil"President:Research|
|Louis J Arcudi IIISenior VP/CFO/Treasurer/Secy||J Peter Wolf "Pete"Senior VP/General Counsel|
|Robert C FletcherSenior VP:Bus Dev & Strategic Planning||Nancy WyantVP:Clinical Operations|
|Timothy M SullivanVP:Dev Programs & Alliance||Kathryn HavilandVP:Rare Diseases|
|Elizabeth Eberhardt "Liz"VP:Oncology||Robert A Doody Jr "Bob"VP:Investor Relations|